

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.74058013 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.79243630 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.79243630 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.79243630 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.79243630 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.79243630 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.79243630 |
| 8 | detection of other organism (GO:0098543) | 5.23826677 |
| 9 | detection of bacterium (GO:0016045) | 5.06852509 |
| 10 | regulation of RIG-I signaling pathway (GO:0039535) | 4.95354996 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.91991028 |
| 12 | B cell receptor signaling pathway (GO:0050853) | 4.82274119 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.80749602 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.71739514 |
| 15 | cellular extravasation (GO:0045123) | 4.69261782 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.69258936 |
| 17 | leukocyte aggregation (GO:0070486) | 4.51939469 |
| 18 | detection of external biotic stimulus (GO:0098581) | 4.48734012 |
| 19 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.38260839 |
| 20 | interferon-gamma production (GO:0032609) | 4.37497627 |
| 21 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.32566431 |
| 22 | positive thymic T cell selection (GO:0045059) | 4.32528341 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.27354609 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 4.26187619 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.19057757 |
| 26 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.19057757 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19018780 |
| 28 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.16148220 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 4.14506939 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 4.13513563 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.12799517 |
| 32 | microglial cell activation (GO:0001774) | 4.03444100 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.97502433 |
| 34 | response to host immune response (GO:0052572) | 3.97502433 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.95752641 |
| 36 | B cell proliferation (GO:0042100) | 3.95715262 |
| 37 | detection of biotic stimulus (GO:0009595) | 3.94887751 |
| 38 | regulation of B cell differentiation (GO:0045577) | 3.93630317 |
| 39 | positive T cell selection (GO:0043368) | 3.88395306 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.87671423 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.87670986 |
| 42 | neutrophil mediated immunity (GO:0002446) | 3.84699643 |
| 43 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.84447098 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.81847463 |
| 45 | negative T cell selection (GO:0043383) | 3.78423186 |
| 46 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.77079384 |
| 47 | regulation of histone H3-K27 methylation (GO:0061085) | 3.73122407 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72347495 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 3.70793311 |
| 50 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.70786005 |
| 51 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.70765670 |
| 52 | negative regulation of cell killing (GO:0031342) | 3.70765670 |
| 53 | macrophage activation (GO:0042116) | 3.68828129 |
| 54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.67613567 |
| 55 | response to host (GO:0075136) | 3.67613567 |
| 56 | response to host defenses (GO:0052200) | 3.67613567 |
| 57 | myeloid cell activation involved in immune response (GO:0002275) | 3.64971988 |
| 58 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.64505732 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.63525848 |
| 60 | negative thymic T cell selection (GO:0045060) | 3.62406395 |
| 61 | T cell migration (GO:0072678) | 3.61712339 |
| 62 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.59614040 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.58310270 |
| 64 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.54627086 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.52699979 |
| 66 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.52104275 |
| 67 | T cell homeostasis (GO:0043029) | 3.51720681 |
| 68 | cellular response to interleukin-15 (GO:0071350) | 3.50232403 |
| 69 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.49188349 |
| 70 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.47657860 |
| 71 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.47550073 |
| 72 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.46395530 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.45812806 |
| 74 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.42720587 |
| 75 | positive regulation of DNA recombination (GO:0045911) | 3.42241956 |
| 76 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.42114687 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.40823889 |
| 78 | positive regulation of mast cell activation (GO:0033005) | 3.39724949 |
| 79 | T cell selection (GO:0045058) | 3.36922316 |
| 80 | negative regulation of phagocytosis (GO:0050765) | 3.35759098 |
| 81 | cellular response to zinc ion (GO:0071294) | 3.33733518 |
| 82 | B cell homeostasis (GO:0001782) | 3.33207561 |
| 83 | type I interferon signaling pathway (GO:0060337) | 3.30713223 |
| 84 | cellular response to type I interferon (GO:0071357) | 3.30713223 |
| 85 | response to type I interferon (GO:0034340) | 3.30309252 |
| 86 | regulation of mast cell activation (GO:0033003) | 3.30246721 |
| 87 | positive regulation of isotype switching (GO:0045830) | 3.29925923 |
| 88 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.26194485 |
| 89 | regulation of T cell tolerance induction (GO:0002664) | 3.26165345 |
| 90 | regulation of tolerance induction (GO:0002643) | 3.26150140 |
| 91 | leukocyte degranulation (GO:0043299) | 3.25232699 |
| 92 | defense response to protozoan (GO:0042832) | 3.25051099 |
| 93 | thymic T cell selection (GO:0045061) | 3.24818410 |
| 94 | response to interleukin-15 (GO:0070672) | 3.23851928 |
| 95 | myeloid leukocyte mediated immunity (GO:0002444) | 3.23752591 |
| 96 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.22306053 |
| 97 | N-acetylneuraminate metabolic process (GO:0006054) | 3.21951516 |
| 98 | positive regulation of B cell proliferation (GO:0030890) | 3.19317559 |
| 99 | lymphocyte homeostasis (GO:0002260) | 3.17646379 |
| 100 | positive regulation of B cell activation (GO:0050871) | 3.16909180 |
| 101 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.12290363 |
| 102 | T cell lineage commitment (GO:0002360) | 3.09995840 |
| 103 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.09334480 |
| 104 | response to protozoan (GO:0001562) | 3.08932641 |
| 105 | neutrophil activation (GO:0042119) | 3.07642764 |
| 106 | negative regulation of interleukin-6 production (GO:0032715) | 3.06677326 |
| 107 | neutrophil activation involved in immune response (GO:0002283) | 3.06527719 |
| 108 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.05384809 |
| 109 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.04810665 |
| 110 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.04810665 |
| 111 | germinal center formation (GO:0002467) | 3.04429951 |
| 112 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03142722 |
| 113 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.02890209 |
| 114 | negative regulation of innate immune response (GO:0045824) | 3.02494141 |
| 115 | mature B cell differentiation (GO:0002335) | 3.00655730 |
| 116 | B cell mediated immunity (GO:0019724) | 2.99903387 |
| 117 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.99632994 |
| 118 | regulation of regulated secretory pathway (GO:1903305) | 2.98597654 |
| 119 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.98311321 |
| 120 | positive regulation of interleukin-2 production (GO:0032743) | 2.97886473 |
| 121 | response to peptidoglycan (GO:0032494) | 2.96425124 |
| 122 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95400630 |
| 123 | positive regulation of humoral immune response (GO:0002922) | 2.95159477 |
| 124 | positive regulation of mast cell degranulation (GO:0043306) | 2.94343447 |
| 125 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.94343447 |
| 126 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.93926054 |
| 127 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.93926054 |
| 128 | tolerance induction (GO:0002507) | 2.91808760 |
| 129 | negative regulation of type 2 immune response (GO:0002829) | 2.90272911 |
| 130 | T cell receptor signaling pathway (GO:0050852) | 2.88302341 |
| 131 | regulation of B cell proliferation (GO:0030888) | 2.87789510 |
| 132 | regulation of regulatory T cell differentiation (GO:0045589) | 2.84466371 |
| 133 | tRNA methylation (GO:0030488) | 2.82664354 |
| 134 | regulation of isotype switching (GO:0045191) | 2.81210348 |
| 135 | leukocyte homeostasis (GO:0001776) | 2.78536585 |
| 136 | activated T cell proliferation (GO:0050798) | 2.77717026 |
| 137 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.76407512 |
| 138 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.76407512 |
| 139 | T cell differentiation involved in immune response (GO:0002292) | 2.76407512 |
| 140 | lymphocyte proliferation (GO:0046651) | 2.74868788 |
| 141 | granulocyte activation (GO:0036230) | 2.71828776 |
| 142 | superoxide anion generation (GO:0042554) | 2.71035597 |
| 143 | regulation of B cell activation (GO:0050864) | 2.69598685 |
| 144 | T-helper cell differentiation (GO:0042093) | 2.69360356 |
| 145 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.69360356 |
| 146 | positive regulation of B cell mediated immunity (GO:0002714) | 2.67237637 |
| 147 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.67237637 |
| 148 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.66598646 |
| 149 | lymphoid progenitor cell differentiation (GO:0002320) | 2.65852173 |
| 150 | mononuclear cell proliferation (GO:0032943) | 2.65735254 |
| 151 | regulation of germinal center formation (GO:0002634) | 2.64496597 |
| 152 | positive regulation of interferon-alpha production (GO:0032727) | 2.63878297 |
| 153 | mast cell activation (GO:0045576) | 2.63464709 |
| 154 | respiratory burst (GO:0045730) | 2.61405986 |
| 155 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.60642690 |
| 156 | myeloid dendritic cell activation (GO:0001773) | 2.60515810 |
| 157 | B cell activation (GO:0042113) | 2.58358603 |
| 158 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.56417836 |
| 159 | regulation of interleukin-2 production (GO:0032663) | 2.54130411 |
| 160 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.53938925 |
| 161 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53528515 |
| 162 | regulation of necroptotic process (GO:0060544) | 2.53450498 |
| 163 | regulation of respiratory burst (GO:0060263) | 2.52676312 |
| 164 | regulation of interferon-alpha production (GO:0032647) | 2.51945011 |
| 165 | regulation of B cell mediated immunity (GO:0002712) | 2.49372167 |
| 166 | regulation of immunoglobulin production (GO:0002637) | 2.49363525 |
| 167 | alpha-beta T cell activation (GO:0046631) | 2.48544733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.43109504 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.64238766 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.31940426 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.26947945 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.78415437 |
| 6 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.18197247 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18066784 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.90671198 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.83905815 |
| 10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.71199260 |
| 11 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.61933680 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.60532067 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54491298 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.53039245 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45219031 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38880691 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.32655482 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31718307 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.28943610 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28335302 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.24282150 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20193728 |
| 23 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18410217 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.14486948 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.11810651 |
| 26 | * MYB_26560356_Chip-Seq_TH2_Human | 2.11642802 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.06894217 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03085523 |
| 29 | * MYB_26560356_Chip-Seq_TH1_Human | 2.00785357 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93468796 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93289648 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92115024 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.90837861 |
| 34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86139178 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.85187736 |
| 36 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82301941 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78303588 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77446728 |
| 39 | * MYC_22102868_ChIP-Seq_BL_Human | 1.75649701 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.74796283 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74176501 |
| 42 | * MAF_26560356_Chip-Seq_TH1_Human | 1.73000841 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.72559974 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72449155 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.69127113 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.67702795 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67126520 |
| 48 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66892170 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.66229069 |
| 50 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.63491668 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62973115 |
| 52 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58797755 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.57970956 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.57699283 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54449310 |
| 56 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.53675241 |
| 57 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.51282420 |
| 58 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.50116225 |
| 59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49966552 |
| 60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48684398 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48644233 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48368531 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46341376 |
| 64 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.45753034 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.45405793 |
| 66 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43633183 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42734607 |
| 68 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.42295218 |
| 69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.41683082 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.38721902 |
| 71 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.37474190 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36294327 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34154312 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33728901 |
| 75 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33678548 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33188930 |
| 77 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32329322 |
| 78 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32024940 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32024402 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31718926 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30845450 |
| 82 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30097751 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28536273 |
| 84 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26225916 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25594724 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.24641917 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23938564 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23271959 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23256594 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22846071 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22651629 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22053074 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21245066 |
| 94 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.21189206 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20399074 |
| 96 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19000624 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18512244 |
| 98 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16582213 |
| 99 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.16474623 |
| 100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.13706081 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12389073 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.10646544 |
| 103 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.10286979 |
| 104 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.09998208 |
| 105 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08011039 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07030538 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06433907 |
| 108 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.04072934 |
| 109 | MAF_26560356_Chip-Seq_TH2_Human | 1.03501426 |
| 110 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02837452 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02714627 |
| 112 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01258192 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01176767 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.99431445 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98065241 |
| 116 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97594061 |
| 117 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97420610 |
| 118 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97091406 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97067537 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96148631 |
| 121 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95979396 |
| 122 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94710911 |
| 123 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94274936 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93778718 |
| 125 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91723207 |
| 126 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.90756939 |
| 127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89591647 |
| 128 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89574742 |
| 129 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.89310562 |
| 130 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.89274286 |
| 131 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.88994981 |
| 132 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88815110 |
| 133 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88160161 |
| 134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87606186 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87279197 |
| 136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87233116 |
| 137 | * P68_20966046_ChIP-Seq_HELA_Human | 0.81438848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.92088005 |
| 2 | MP0005671_abnormal_response_to | 3.54275545 |
| 3 | MP0005387_immune_system_phenotype | 3.21254480 |
| 4 | MP0001790_abnormal_immune_system | 3.21254480 |
| 5 | MP0001800_abnormal_humoral_immune | 3.16038779 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.11182427 |
| 7 | MP0000685_abnormal_immune_system | 3.09025197 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 2.73574076 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.63272941 |
| 10 | MP0009785_altered_susceptibility_to | 2.60933414 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.55047326 |
| 12 | MP0002723_abnormal_immune_serum | 2.52305165 |
| 13 | MP0004381_abnormal_hair_follicle | 2.50285611 |
| 14 | MP0002420_abnormal_adaptive_immunity | 2.49028177 |
| 15 | MP0001819_abnormal_immune_cell | 2.45947968 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.30287485 |
| 17 | MP0002398_abnormal_bone_marrow | 2.27215100 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.23916028 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.22316393 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.18864446 |
| 21 | MP0002419_abnormal_innate_immunity | 2.14164379 |
| 22 | MP0000716_abnormal_immune_system | 2.12778421 |
| 23 | MP0005025_abnormal_response_to | 2.11247861 |
| 24 | MP0003693_abnormal_embryo_hatching | 2.05883624 |
| 25 | MP0000689_abnormal_spleen_morphology | 2.01334230 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.99171590 |
| 27 | MP0003866_abnormal_defecation | 1.96500942 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.93330909 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.90890255 |
| 30 | MP0000015_abnormal_ear_pigmentation | 1.89418593 |
| 31 | MP0009278_abnormal_bone_marrow | 1.89203742 |
| 32 | MP0002722_abnormal_immune_system | 1.84220115 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.81881676 |
| 34 | MP0008260_abnormal_autophagy | 1.79293802 |
| 35 | MP0004510_myositis | 1.78008879 |
| 36 | MP0003436_decreased_susceptibility_to | 1.77617573 |
| 37 | MP0001873_stomach_inflammation | 1.70990946 |
| 38 | MP0002429_abnormal_blood_cell | 1.69511372 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.62723449 |
| 40 | MP0002405_respiratory_system_inflammati | 1.56572333 |
| 41 | MP0010386_abnormal_urinary_bladder | 1.52995379 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.52703981 |
| 43 | MP0002933_joint_inflammation | 1.51993131 |
| 44 | MP0008058_abnormal_DNA_repair | 1.47257255 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.45717286 |
| 46 | MP0002693_abnormal_pancreas_physiology | 1.44713172 |
| 47 | MP0005409_darkened_coat_color | 1.41972159 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.41941204 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.40340002 |
| 50 | MP0002006_tumorigenesis | 1.40316582 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.40061733 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.39363930 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.39363930 |
| 54 | MP0004883_abnormal_blood_vessel | 1.37373129 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.36648963 |
| 56 | MP0008057_abnormal_DNA_replication | 1.36076735 |
| 57 | MP0001851_eye_inflammation | 1.33659009 |
| 58 | MP0001853_heart_inflammation | 1.32341186 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.31438890 |
| 60 | MP0001188_hyperpigmentation | 1.29675867 |
| 61 | MP0003724_increased_susceptibility_to | 1.26850640 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.25425908 |
| 63 | MP0002009_preneoplasia | 1.24131887 |
| 64 | MP0005310_abnormal_salivary_gland | 1.20371384 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.19412892 |
| 66 | MP0000490_abnormal_crypts_of | 1.18518098 |
| 67 | MP0003111_abnormal_nucleus_morphology | 1.18437248 |
| 68 | MP0004947_skin_inflammation | 1.18186686 |
| 69 | MP0003075_altered_response_to | 1.09864368 |
| 70 | MP0005379_endocrine/exocrine_gland_phen | 1.08719594 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.07314279 |
| 72 | MP0003879_abnormal_hair_cell | 1.06691292 |
| 73 | MP0006082_CNS_inflammation | 1.06583027 |
| 74 | MP0005164_abnormal_response_to | 1.04052147 |
| 75 | MP0003303_peritoneal_inflammation | 1.00633201 |
| 76 | MP0002928_abnormal_bile_duct | 1.00358381 |
| 77 | MP0003690_abnormal_glial_cell | 0.99322028 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 0.99138964 |
| 79 | MP0002163_abnormal_gland_morphology | 0.98642205 |
| 80 | MP0008469_abnormal_protein_level | 0.98109650 |
| 81 | MP0002138_abnormal_hepatobiliary_system | 0.97563252 |
| 82 | MP0010094_abnormal_chromosome_stability | 0.96569904 |
| 83 | MP0005058_abnormal_lysosome_morphology | 0.96236609 |
| 84 | MP0003943_abnormal_hepatobiliary_system | 0.93059935 |
| 85 | MP0006292_abnormal_olfactory_placode | 0.91322858 |
| 86 | MP0005451_abnormal_body_composition | 0.90859539 |
| 87 | MP0005166_decreased_susceptibility_to | 0.90337493 |
| 88 | MP0005390_skeleton_phenotype | 0.89712281 |
| 89 | MP0003868_abnormal_feces_composition | 0.88284519 |
| 90 | MP0000372_irregular_coat_pigmentation | 0.88092995 |
| 91 | MP0001663_abnormal_digestive_system | 0.84064573 |
| 92 | MP0009840_abnormal_foam_cell | 0.81568737 |
| 93 | MP0002132_abnormal_respiratory_system | 0.81242431 |
| 94 | MP0009763_increased_sensitivity_to | 0.81188563 |
| 95 | MP0001186_pigmentation_phenotype | 0.80555355 |
| 96 | MP0003077_abnormal_cell_cycle | 0.79534818 |
| 97 | MP0004130_abnormal_muscle_cell | 0.77715076 |
| 98 | MP0000371_diluted_coat_color | 0.76841781 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.75413356 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.75370183 |
| 101 | MP0001764_abnormal_homeostasis | 0.75366147 |
| 102 | MP0003448_altered_tumor_morphology | 0.74541848 |
| 103 | MP0003045_fibrosis | 0.73721007 |
| 104 | MP0001944_abnormal_pancreas_morphology | 0.73228747 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.73110835 |
| 106 | MP0008004_abnormal_stomach_pH | 0.72273151 |
| 107 | MP0002019_abnormal_tumor_incidence | 0.69945664 |
| 108 | MP0002075_abnormal_coat/hair_pigmentati | 0.68380233 |
| 109 | MP0005083_abnormal_biliary_tract | 0.67511511 |
| 110 | MP0000858_altered_metastatic_potential | 0.67031601 |
| 111 | MP0000604_amyloidosis | 0.66589744 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.66315040 |
| 113 | MP0000343_altered_response_to | 0.65265693 |
| 114 | MP0009765_abnormal_xenobiotic_induced | 0.64772316 |
| 115 | MP0003795_abnormal_bone_structure | 0.64752337 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.64271300 |
| 117 | MP0000249_abnormal_blood_vessel | 0.63475248 |
| 118 | MP0002168_other_aberrant_phenotype | 0.62683299 |
| 119 | MP0003787_abnormal_imprinting | 0.62590197 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.62295595 |
| 121 | MP0008874_decreased_physiological_sensi | 0.61592947 |
| 122 | MP0001533_abnormal_skeleton_physiology | 0.60202321 |
| 123 | MP0003828_pulmonary_edema | 0.60201367 |
| 124 | MP0003786_premature_aging | 0.60009709 |
| 125 | MP0009764_decreased_sensitivity_to | 0.57851567 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.55987016 |
| 127 | MP0005388_respiratory_system_phenotype | 0.53018223 |
| 128 | MP0002133_abnormal_respiratory_system | 0.53018223 |
| 129 | MP0001958_emphysema | 0.52197907 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.51862285 |
| 131 | MP0003806_abnormal_nucleotide_metabolis | 0.50655027 |
| 132 | MP0002332_abnormal_exercise_endurance | 0.49742038 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.49403884 |
| 134 | MP0005377_hearing/vestibular/ear_phenot | 0.48768518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 5.45475741 |
| 2 | Agammaglobulinemia (HP:0004432) | 4.96656943 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 4.50105134 |
| 4 | Gastrointestinal infarctions (HP:0005244) | 4.46968017 |
| 5 | Stomatitis (HP:0010280) | 4.38677015 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.14435476 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.13188329 |
| 8 | Meningitis (HP:0001287) | 3.97731738 |
| 9 | IgM deficiency (HP:0002850) | 3.92292785 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.88933360 |
| 11 | Increased IgE level (HP:0003212) | 3.86109595 |
| 12 | Spontaneous hematomas (HP:0007420) | 3.80168038 |
| 13 | Recurrent viral infections (HP:0004429) | 3.78499799 |
| 14 | Eczematoid dermatitis (HP:0000976) | 3.77757952 |
| 15 | Keratoconjunctivitis sicca (HP:0001097) | 3.71683512 |
| 16 | Recurrent bronchitis (HP:0002837) | 3.64519955 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.62585083 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.60970914 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.60970914 |
| 20 | T lymphocytopenia (HP:0005403) | 3.60686048 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.56232327 |
| 22 | B lymphocytopenia (HP:0010976) | 3.56232327 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.53842110 |
| 24 | IgG deficiency (HP:0004315) | 3.53248684 |
| 25 | Hypochromic microcytic anemia (HP:0004840) | 3.50218720 |
| 26 | Abnormality of T cell number (HP:0011839) | 3.49942211 |
| 27 | Thyroiditis (HP:0100646) | 3.46306660 |
| 28 | Chest pain (HP:0100749) | 3.45840300 |
| 29 | Keratoconjunctivitis (HP:0001096) | 3.45576112 |
| 30 | Chronic diarrhea (HP:0002028) | 3.43175130 |
| 31 | Gastrointestinal stroma tumor (HP:0100723) | 3.42396211 |
| 32 | Abnormality of T cells (HP:0002843) | 3.41136050 |
| 33 | Urticaria (HP:0001025) | 3.37643029 |
| 34 | Hypochromic anemia (HP:0001931) | 3.32551197 |
| 35 | Chronic otitis media (HP:0000389) | 3.30854943 |
| 36 | Severe combined immunodeficiency (HP:0004430) | 3.29255593 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 3.17673068 |
| 38 | Abnormality of the fingertips (HP:0001211) | 3.17169969 |
| 39 | Hemoptysis (HP:0002105) | 3.16825869 |
| 40 | Lymphopenia (HP:0001888) | 3.04927336 |
| 41 | Episodic fever (HP:0001954) | 2.99220160 |
| 42 | Chronic sinusitis (HP:0011109) | 2.97437236 |
| 43 | Recurrent sinusitis (HP:0011108) | 2.97077909 |
| 44 | Gingivitis (HP:0000230) | 2.94790683 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.94106392 |
| 46 | Obstructive lung disease (HP:0006536) | 2.94106392 |
| 47 | Epistaxis (HP:0000421) | 2.91797853 |
| 48 | Increased IgM level (HP:0003496) | 2.91587066 |
| 49 | Pustule (HP:0200039) | 2.91090285 |
| 50 | Vasculitis (HP:0002633) | 2.90719757 |
| 51 | Gingival bleeding (HP:0000225) | 2.89966312 |
| 52 | Peritonitis (HP:0002586) | 2.89245362 |
| 53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.86771322 |
| 54 | Recurrent skin infections (HP:0001581) | 2.85937162 |
| 55 | Arterial thrombosis (HP:0004420) | 2.83191741 |
| 56 | Cellulitis (HP:0100658) | 2.82472738 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.80407001 |
| 58 | Hypoplasia of the thymus (HP:0000778) | 2.78874549 |
| 59 | Pulmonary embolism (HP:0002204) | 2.77601922 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.76430575 |
| 61 | IgA deficiency (HP:0002720) | 2.72745079 |
| 62 | Recurrent pneumonia (HP:0006532) | 2.70234248 |
| 63 | Abnormal hair whorl (HP:0010721) | 2.69922294 |
| 64 | Amyloidosis (HP:0011034) | 2.67886927 |
| 65 | Combined immunodeficiency (HP:0005387) | 2.64215189 |
| 66 | Lymphoma (HP:0002665) | 2.63236549 |
| 67 | Neutropenia (HP:0001875) | 2.62457089 |
| 68 | Encephalitis (HP:0002383) | 2.61937776 |
| 69 | Anorexia (HP:0002039) | 2.61817956 |
| 70 | Abnormality of macrophages (HP:0004311) | 2.60936440 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 2.57030024 |
| 72 | Eosinophilia (HP:0001880) | 2.56819523 |
| 73 | Colitis (HP:0002583) | 2.51934880 |
| 74 | Cheilitis (HP:0100825) | 2.49308511 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.48122161 |
| 76 | Basal ganglia calcification (HP:0002135) | 2.45523193 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.44495596 |
| 78 | Petechiae (HP:0000967) | 2.44314461 |
| 79 | Microcytic anemia (HP:0001935) | 2.42946272 |
| 80 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.42841366 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40738569 |
| 82 | Abnormality of the peritoneum (HP:0002585) | 2.40471044 |
| 83 | Granulocytopenia (HP:0001913) | 2.35570395 |
| 84 | Microvesicular hepatic steatosis (HP:0001414) | 2.33603354 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31658822 |
| 86 | Gangrene (HP:0100758) | 2.29052557 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.26910557 |
| 88 | Optic neuritis (HP:0100653) | 2.26910557 |
| 89 | Leukopenia (HP:0001882) | 2.21482625 |
| 90 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21123804 |
| 91 | Abnormality of DNA repair (HP:0003254) | 2.19295630 |
| 92 | Viral hepatitis (HP:0006562) | 2.18540102 |
| 93 | Osteomyelitis (HP:0002754) | 2.18460399 |
| 94 | Mitral stenosis (HP:0001718) | 2.17800273 |
| 95 | Chromsome breakage (HP:0040012) | 2.17433786 |
| 96 | Type I transferrin isoform profile (HP:0003642) | 2.16972722 |
| 97 | Emphysema (HP:0002097) | 2.16325603 |
| 98 | Myositis (HP:0100614) | 2.15630569 |
| 99 | Skin ulcer (HP:0200042) | 2.14220624 |
| 100 | Abnormality of the endocardium (HP:0004306) | 2.12732590 |
| 101 | Hepatosplenomegaly (HP:0001433) | 2.11154169 |
| 102 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09822827 |
| 103 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09822827 |
| 104 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09822827 |
| 105 | Vacuolated lymphocytes (HP:0001922) | 2.07914040 |
| 106 | Increased serum ferritin (HP:0003281) | 2.07867172 |
| 107 | Reduced antithrombin III activity (HP:0001976) | 2.07695333 |
| 108 | Renal cortical cysts (HP:0000803) | 2.06571734 |
| 109 | Glomerulopathy (HP:0100820) | 2.06387280 |
| 110 | Leukocytosis (HP:0001974) | 2.05754594 |
| 111 | Purpura (HP:0000979) | 2.05480264 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.02127492 |
| 113 | Bronchitis (HP:0012387) | 2.01201185 |
| 114 | Acne (HP:0001061) | 1.99247662 |
| 115 | Hypoproteinemia (HP:0003075) | 1.99061060 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 1.98516631 |
| 117 | Sepsis (HP:0100806) | 1.96546370 |
| 118 | Slow saccadic eye movements (HP:0000514) | 1.96181208 |
| 119 | Restrictive lung disease (HP:0002091) | 1.96019000 |
| 120 | Abnormal platelet volume (HP:0011876) | 1.95320269 |
| 121 | Verrucae (HP:0200043) | 1.95117952 |
| 122 | Papilloma (HP:0012740) | 1.95117952 |
| 123 | Vertigo (HP:0002321) | 1.95040987 |
| 124 | Acute hepatic failure (HP:0006554) | 1.94089381 |
| 125 | Prolonged bleeding time (HP:0003010) | 1.93940867 |
| 126 | Keratitis (HP:0000491) | 1.93650727 |
| 127 | Papilledema (HP:0001085) | 1.93282981 |
| 128 | Autoimmune thrombocytopenia (HP:0001973) | 1.92531642 |
| 129 | Abnormality of the pericardium (HP:0001697) | 1.92294735 |
| 130 | Pulmonary infiltrates (HP:0002113) | 1.90190893 |
| 131 | Skin rash (HP:0000988) | 1.89506939 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.86804319 |
| 133 | Clubbing of toes (HP:0100760) | 1.86301143 |
| 134 | Premature loss of primary teeth (HP:0006323) | 1.85727822 |
| 135 | Decreased circulating renin level (HP:0003351) | 1.84036893 |
| 136 | 3-Methylglutaconic aciduria (HP:0003535) | 1.83992973 |
| 137 | Periodontitis (HP:0000704) | 1.82505628 |
| 138 | Abnormality of the prostate (HP:0008775) | 1.82135436 |
| 139 | Metaphyseal cupping (HP:0003021) | 1.80827699 |
| 140 | Recurrent otitis media (HP:0000403) | 1.78631189 |
| 141 | Entropion (HP:0000621) | 1.77795060 |
| 142 | Prolonged neonatal jaundice (HP:0006579) | 1.76535561 |
| 143 | Stomach cancer (HP:0012126) | 1.74860038 |
| 144 | Birth length less than 3rd percentile (HP:0003561) | 1.74309767 |
| 145 | Febrile seizures (HP:0002373) | 1.73076805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.34214322 |
| 2 | TXK | 3.65500661 |
| 3 | IRAK3 | 3.19624259 |
| 4 | ERN1 | 3.00358018 |
| 5 | MAP3K14 | 2.83163738 |
| 6 | IRAK4 | 2.60830849 |
| 7 | RIPK4 | 2.20267375 |
| 8 | ZAP70 | 2.19158510 |
| 9 | INSRR | 2.16215191 |
| 10 | JAK3 | 2.15312395 |
| 11 | EPHB1 | 2.04384354 |
| 12 | ZAK | 1.88181749 |
| 13 | MAP3K13 | 1.85420954 |
| 14 | BUB1 | 1.84543285 |
| 15 | IKBKE | 1.81556956 |
| 16 | SYK | 1.80763016 |
| 17 | EIF2AK3 | 1.80212079 |
| 18 | TEC | 1.78532184 |
| 19 | NLK | 1.73329674 |
| 20 | TAOK1 | 1.72652125 |
| 21 | MAP3K3 | 1.72145528 |
| 22 | STK16 | 1.71349843 |
| 23 | IKBKB | 1.68120017 |
| 24 | BTK | 1.61990411 |
| 25 | MAP3K11 | 1.57814816 |
| 26 | FGR | 1.56322878 |
| 27 | MAP3K12 | 1.54779942 |
| 28 | TYK2 | 1.53831134 |
| 29 | TNIK | 1.39494392 |
| 30 | JAK2 | 1.37344659 |
| 31 | BLK | 1.35627006 |
| 32 | SIK3 | 1.34638763 |
| 33 | CASK | 1.31046278 |
| 34 | JAK1 | 1.30600308 |
| 35 | YES1 | 1.30346933 |
| 36 | MAPK15 | 1.30054824 |
| 37 | ITK | 1.28535622 |
| 38 | MAP3K1 | 1.28380136 |
| 39 | KIT | 1.27018942 |
| 40 | TRIB3 | 1.26460626 |
| 41 | CLK1 | 1.24365238 |
| 42 | LCK | 1.23944215 |
| 43 | EIF2AK2 | 1.23248983 |
| 44 | GRK6 | 1.22191586 |
| 45 | TAOK3 | 1.20960660 |
| 46 | HCK | 1.20955876 |
| 47 | CHUK | 1.18008362 |
| 48 | MARK2 | 1.17623048 |
| 49 | PIM1 | 1.15806451 |
| 50 | LYN | 1.15803501 |
| 51 | FES | 1.15268799 |
| 52 | MARK3 | 1.14626743 |
| 53 | SIK2 | 1.13803304 |
| 54 | KSR2 | 1.12228172 |
| 55 | PTK6 | 1.09438194 |
| 56 | EPHA2 | 1.05492984 |
| 57 | MAP3K10 | 1.04138900 |
| 58 | PIK3CG | 1.02652441 |
| 59 | SGK2 | 1.00170602 |
| 60 | MAP3K7 | 0.97696276 |
| 61 | TSSK6 | 0.97458382 |
| 62 | TNK2 | 0.96700758 |
| 63 | TBK1 | 0.93955286 |
| 64 | SGK3 | 0.93066595 |
| 65 | CSF1R | 0.92847302 |
| 66 | BMPR2 | 0.92464938 |
| 67 | HIPK2 | 0.90220122 |
| 68 | PASK | 0.90206010 |
| 69 | MAPK7 | 0.89562352 |
| 70 | CSK | 0.89377810 |
| 71 | PDK1 | 0.89260862 |
| 72 | SRPK1 | 0.88289570 |
| 73 | CAMKK2 | 0.86331776 |
| 74 | WEE1 | 0.82815423 |
| 75 | MAP3K6 | 0.80931569 |
| 76 | STK10 | 0.80359596 |
| 77 | IRAK2 | 0.80311479 |
| 78 | MATK | 0.79968606 |
| 79 | SMG1 | 0.79626865 |
| 80 | TLK1 | 0.78574381 |
| 81 | BRSK2 | 0.78164663 |
| 82 | CCNB1 | 0.77552112 |
| 83 | PDPK1 | 0.77298283 |
| 84 | PTK2B | 0.76712297 |
| 85 | MAPK12 | 0.76346066 |
| 86 | PIM2 | 0.75728385 |
| 87 | ACVR1B | 0.72959089 |
| 88 | TESK2 | 0.71863961 |
| 89 | ARAF | 0.70130956 |
| 90 | TAOK2 | 0.69129944 |
| 91 | BRD4 | 0.68885688 |
| 92 | CDC42BPA | 0.68295854 |
| 93 | LRRK2 | 0.67692730 |
| 94 | STK24 | 0.67410734 |
| 95 | FGFR4 | 0.65782555 |
| 96 | SIK1 | 0.65642908 |
| 97 | DYRK1B | 0.65256940 |
| 98 | FGFR3 | 0.65255493 |
| 99 | PRKCQ | 0.63872659 |
| 100 | FYN | 0.63744980 |
| 101 | CDK19 | 0.63265636 |
| 102 | TGFBR2 | 0.62915029 |
| 103 | STK11 | 0.62791176 |
| 104 | STK4 | 0.60486801 |
| 105 | MAP2K4 | 0.60435212 |
| 106 | PNCK | 0.60020330 |
| 107 | GRK1 | 0.59883969 |
| 108 | CDK3 | 0.59033070 |
| 109 | FRK | 0.58852198 |
| 110 | DAPK2 | 0.57525061 |
| 111 | MAP3K2 | 0.54707521 |
| 112 | STK38 | 0.53648755 |
| 113 | MAP2K6 | 0.53068306 |
| 114 | RPS6KA5 | 0.52535500 |
| 115 | MAPK4 | 0.51882914 |
| 116 | VRK1 | 0.51791583 |
| 117 | RPS6KL1 | 0.51605923 |
| 118 | RPS6KC1 | 0.51605923 |
| 119 | RET | 0.51081085 |
| 120 | NME2 | 0.49560370 |
| 121 | EPHA3 | 0.47750804 |
| 122 | BRAF | 0.47283441 |
| 123 | MKNK2 | 0.46663765 |
| 124 | MELK | 0.46294054 |
| 125 | PRKCH | 0.44806457 |
| 126 | ADRBK2 | 0.44755362 |
| 127 | CAMKK1 | 0.44502807 |
| 128 | NUAK1 | 0.43654522 |
| 129 | CDK4 | 0.43455916 |
| 130 | PRPF4B | 0.43410196 |
| 131 | PRKD2 | 0.41884038 |
| 132 | ATR | 0.40715755 |
| 133 | PRKCD | 0.40296208 |
| 134 | CAMK1 | 0.40023183 |
| 135 | MAP3K5 | 0.39691590 |
| 136 | BRSK1 | 0.39561403 |
| 137 | RPS6KA6 | 0.38710217 |
| 138 | MAP2K7 | 0.38482808 |
| 139 | GRK7 | 0.37903693 |
| 140 | WNK1 | 0.37115444 |
| 141 | RAF1 | 0.36720043 |
| 142 | PKN2 | 0.36401406 |
| 143 | MAPKAPK2 | 0.35972616 |
| 144 | IRAK1 | 0.35353727 |
| 145 | PRKCI | 0.33360587 |
| 146 | MAP2K3 | 0.33180672 |
| 147 | RPS6KB1 | 0.32979400 |
| 148 | CDK12 | 0.32060079 |
| 149 | MAP2K2 | 0.29569464 |
| 150 | PRKCZ | 0.28863761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.72799058 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.95582236 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76243276 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.66921091 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.59288331 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.55349616 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.51151870 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.33552477 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.08649471 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.04377727 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.98362166 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.92968706 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91601796 |
| 14 | Measles_Homo sapiens_hsa05162 | 1.87498772 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.71860482 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.69622235 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69127110 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68685998 |
| 19 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.67707479 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.61904724 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61041332 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.57997189 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57651919 |
| 24 | * Regulation of autophagy_Homo sapiens_hsa04140 | 1.56343977 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52398141 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.46627187 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.46483476 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.46280754 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41203287 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40664362 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34251639 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28827466 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.27658176 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.27375651 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.22671134 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.20273807 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13950604 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10242497 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.06460058 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02619160 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01597085 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01341886 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00784656 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00483005 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97914482 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97902703 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 0.95783464 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91862639 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.87342643 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.84476791 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83662745 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.83078817 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82980020 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82792976 |
| 55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82082046 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.81009468 |
| 57 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78749381 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78581887 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.78013149 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 0.77924957 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77846864 |
| 62 | DNA replication_Homo sapiens_hsa03030 | 0.77820778 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77508909 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74502772 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74040770 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73338036 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72847656 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71642134 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71562321 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.71442883 |
| 71 | Nicotine addiction_Homo sapiens_hsa05033 | 0.70374746 |
| 72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69428679 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69383899 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69214800 |
| 75 | Mismatch repair_Homo sapiens_hsa03430 | 0.68739451 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68150376 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67960836 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66311962 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66155105 |
| 80 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65875207 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.65190792 |
| 82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65120412 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64188449 |
| 84 | RNA polymerase_Homo sapiens_hsa03020 | 0.63086891 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62639746 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.62386129 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62095396 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61866433 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.60939292 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60246821 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.58931420 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.57958174 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.56177423 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55923922 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.55327097 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54474349 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54083317 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.53566939 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51917388 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51259039 |
| 101 | Spliceosome_Homo sapiens_hsa03040 | 0.50909038 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.48993647 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.47895211 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47605434 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46207905 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45512354 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45163473 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44603281 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42786650 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41821784 |
| 111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41807950 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.41788257 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41722558 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41201738 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41062809 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40312202 |
| 117 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39045153 |
| 118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38883394 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.37612797 |
| 120 | Purine metabolism_Homo sapiens_hsa00230 | 0.36976753 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36752710 |
| 122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36490965 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.34705028 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34124025 |
| 125 | RNA degradation_Homo sapiens_hsa03018 | 0.33253418 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32821347 |
| 127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32465095 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.32105625 |
| 129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30513750 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30025416 |
| 131 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28879818 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.28200153 |
| 133 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27888574 |

